Outlook Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Outlook Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Outlook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.4M, a 1.05% increase year-over-year.
  • Outlook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $5.37M, a 2.98% decline year-over-year.
  • Outlook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.55M, a 28.1% decline from 2022.
  • Outlook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.71M, a 57.8% increase from 2021.
  • Outlook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.89M, a 74.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.55M -$2.16M -28.1% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-22
2022 $7.71M +$2.82M +57.8% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-22
2021 $4.89M +$2.08M +74.1% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-29
2020 $2.81M +$1.49M +114% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 $1.31M Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.